$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
ResMed (NYSE:RMD) has outperformed the market over the past 10 years by 4.86% on an annualized basis producing an average annual return of 15.65%. Currently, ResMed has a market capitalization of $32.
Quest Diagnostics Declares $0.75 Dividend
Most Shorted S&P 500 Stocks as a Percentage of Float
Short Interest in S&P 500 Healthcare Sector Dips in April, Biotechnology Companies Most Shorted
Employers Struggle With Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High
Cheating on drug tests among American workers has surged to its highest level in over 30 years, according to a lab report from Quest Diagnostics Inc (NASDAQ:DGX).The lab reported that approximately 31
Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market
On Tuesday, Blue Orca Capital released a report on Insulet Corporation (NASDAQ:PODD), saying it is short on the insulin delivery patch pump manufacturer.The report added that Blue Orca is long on its
$100 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 3.51% on an annualized basis producing an average annual return of 14.27%. Currently, Agilent Technologies has a mar
Quest Diagnostics Said to Be Nearing Deal for Canada's Lifelabs
Twist Bioscience Launches MGF Product, Stock Climbs 10%
QIAGEN Gets FDA Clearance for QIAstat-Dx Respiratory Panel Plus
10 Financials Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
AU Evening Wrap: ASX Rally Late to Close Flat; Fletcher Plummets 11%
Consumer and health stocks were the best performers as the benchmark index rallied from almost 0.4% down over the last hour of Monday's session.
Earnings Call Summary | Insulet(PODD.US) Q1 2024 Earnings Conference
The following is a summary of the Insulet Corporation (PODD) Q1 2024 Earnings Call Transcript:Financial Performance:Insulet Corporation exceeded Q1 2024 expectations with 21% growth in total Omnipod r
10 Health Care Stocks With Whale Alerts In Today's Session
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth.
Agilent Has New CEO With Padraig McDonnell
Cathie Wood's Ark Invest Purchases Over $30M of Shopify Shares Amid Q1 Numbers-Driven Plunge; Adds Reddit Shares To Kitty — Offloads Coinbase Stock As Bitcoin Declines
On Wednesday, Cathie Wood's Ark Invest made some significant trades. The most prominent among these were the purchases of Shopify Inc (NYSE:SHOP) and Reddit Inc (NYSE:RDDT), and the selling off of Coi
Tandem Diabetes Care Recalls Version 2.7 Of Apple iOS T:Connect Mobile App Used With T:Slim X2 Insulin Pump With Control-IQ Technology
Tandem Diabetes Care Recalls Version 2.7 Of Apple iOS T:Connect Mobile App Used With T:Slim X2 Insulin Pump With Control-IQ Technology
Cathie Wood's Ark Invest Swoops In To Buy The Palantir Dip — Purchases Stock Worth $29M — Offloads Coinbase Shares Worth Over $15M Amid Softening Bitcoin Price
On Tuesday, the Cathie Wood-led Ark Invest made some significant trades. The most prominent among them were the increased stakes in Palantir Technologies Inc (NYSE:PLTR) and the reduced holdings in Co
Oscar Health | 10-Q: Quarterly report
Wolfe Raises Insulet to Outperform, Cites Increasing Market Share